ArticleBiomedicines2026
Targeting the FTO-ACSL4 Pathway: A Novel Mechanism for Sanguinarine Chloride-Induced Ferroptosis in Endometrial Cancer.
Wenyan Li, Shanhui Liu, Ke Wang, Jianzhong Lu, Shengjun Fu, Lanlan Li, Yan Tao
Abstract read
In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Wenyan LiDepartment of Gynaecology and Obstetrics, The Second Hospital of Lanzhou University, No. 82 Cuiyingmen, Lanzhou 730030, China.
Shanhui LiuInstitute of Urology, Gansu Province Clinical Research Center for Urinary System Diseases, The Second Hospital of Lanzhou University, No. 82 Cuiyingmen, Lanzhou 730030, China.
Ke WangThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Jianzhong LuInstitute of Urology, Gansu Province Clinical Research Center for Urinary System Diseases, The Second Hospital of Lanzhou University, No. 82 Cuiyingmen, Lanzhou 730030, China.
Shengjun FuInstitute of Urology, Gansu Province Clinical Research Center for Urinary System Diseases, The Second Hospital of Lanzhou University, No. 82 Cuiyingmen, Lanzhou 730030, China.
Lanlan LiInstitute of Urology, Gansu Province Clinical Research Center for Urinary System Diseases, The Second Hospital of Lanzhou University, No. 82 Cuiyingmen, Lanzhou 730030, China.
Yan TaoInstitute of Urology, Gansu Province Clinical Research Center for Urinary System Diseases, The Second Hospital of Lanzhou University, No. 82 Cuiyingmen, Lanzhou 730030, China.ORCID 0009-0006-3744-2795 Funding
Gansu Province Health and Wellness Industry Research Project GSWSKY2025-42Natural Science Foundation Project of Gansu Province 25JRRA610the Cuiying Scientifc Training Program for Undergraduates of Lanzhou University Second Hospital CYXZPT2025-02the Gansu Provincial Health Industry Science and Technology Innovation Project GSWSQNPY2024-12the Key Incubation Project Funds of the second hospital & clinical medical school, lanzhou uni-versity 2025-22-zdfy-005the Key Incubation Project Funds of the second hospital & clinical medical school, lanzhou university 2025-24-zdfy-019the Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases 2024-KFMS-2Traditional Chinese Medicine Scientifc Research Project of Gansu Province, China GZKP2023-36
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
ACSL4endometrial cancerferroptosisFTOsanguinarine chloride
Identifiers
PMID41898255
PMCPMC13024624
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390